Areterna, a Synthgene Company

Areterna was founded in 2023 as a wholly-owned subsidiary of Synthgene Biotechnology Co., Ltd. We provide raw materials and services to support mRNA and oligonucleotide manufacturing. Our company has a robust quality system and ISO9001 certification to support cGMP manufacturing of mRNA raw materials that include NTPs, modified NTPs and cap analogs. In addition, we offer analytical development services for mRNA-related impurity standards and detection kits, LNP screening service, IVT process development and IVT kits for mRNA research.

CONNECT 

Visit us at www.areterna.com
Inquiries: sales@areterna.com
LinkedIn: linkedin.com/company/areterna-llc